Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)

Investing

Published: January 28, 2009 8:40 am

Last Updated: April 28, 2020 8:36 am

Burning_money_pic These are some of the top pre-market downgrades and cautious calls we have seen from Wall Street analysts this Wednesday morning:

Amylin Pharmaceuticals (AMLN) Cut to Sell at Canaccord Adams.
Biogen Idec (BIIB) Started as Sell at Brean Murray.
Ciena (CIEN) Cut to Underperform at Credit Suisse.
Exxon Mobil (XOM) Cut to Neutral at UBS.
Gafisa (GFA) Cut to Neutral at UBS.
Maxim Integrated (MXIM) Cut to Equal Weight at Barclays.
Peabody Energy (BTU) Cut to Market Perform at FBR.
Sterlite Industries (SLT) Cut to Sell at Citigroup.
Sunpower (SPWRA) Cut to Accumulate at ThinkEquity.

Jon C. Ogg
January 28, 2009

Cash Back Credit Cards Have Never Been This Good

Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.